On May 1, 2020, Athersys and University Hospitals Cleveland Medical Center (UH Cleveland) announced that UH Cleveland is…
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) received notice that its SARS-CoV-2 qPCR Kit had complied with…
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics hasd entered into a…
On Apr. 30, 2020, the FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
On Apr. 30, 2020, University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for…
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements,…
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
On Apr. 30, 2020, Vaxart announced it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 30, 2020, Mateon Therapeutics reported several peer-reviewed publications derived from its R&D effort against COVID-19. Published…
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
On Apr. 30, 2020, Tyson announced a partnership with Matrix Medical Network to help ensure the safety and…
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaﾮ molecular assay to detect…
On Apr. 29, 2020, hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than…
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…